Bruno Pharma

Bruno Pharma appears to be a healthcare technology company focused on diabetes and metabolic monitoring rather than a therapeutic biotech or drug-development company. Its primary commercial offering is the Bruno MD6 blood ketone and glucose monitoring system, which is marketed for at-home use and paired with a mobile app and telehealth data-sharing tools. The product positioning emphasizes plasma-calibrated glucose measurement, 5-electrode sensing technology, ketone monitoring, and remote sharing of patient data with physicians, caregivers, and family members. Available public information indicates the company is based in Boca Raton, Florida and operates through the brunomd6.com brand presence. The evidence does not indicate a conventional drug pipeline, clinical-stage therapeutics portfolio, or specific molecular targets.